Literature DB >> 15142612

Bipolar depression: the real challenge.

Robert M A Hirschfeld1.   

Abstract

This paper seeks to raise awareness of the impact and burden of bipolar depression and the need to improve its recognition and management in clinical practice. Bipolar depression is commonly misdiagnosed as unipolar depression and consequently, patients may receive inappropriate treatment that could potentially worsen symptoms. The Mood Disorder Questionnaire (MDQ) is a useful screening tool for identifying the range of bipolar spectrum disorders in general and psychiatric populations. Bipolar depression has a significant impact on patients, affecting work, social activities, family and friends. Current treatments for bipolar disorder have focused on mania, yet symptoms of bipolar depression occur more frequently, last longer, are more disruptive and are associated with greater risk of suicide than mania. In comparison with unipolar depression, bipolar depression is more severe, is associated with more frequent hospital visits and causes greater psychosocial impairment. These facts emphasise the importance of improving the diagnosis and treatment of bipolar depression.

Entities:  

Mesh:

Year:  2004        PMID: 15142612     DOI: 10.1016/j.euroneuro.2004.03.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  9 in total

1.  Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers.

Authors:  Ronald C Kessler; Hagop S Akiskal; Minnie Ames; Howard Birnbaum; Paul Greenberg; Robert M A Hirschfeld; Robert Jin; Kathleen R Merikangas; Gregory E Simon; Philip S Wang
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

2.  Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses.

Authors:  Michael D Stensland; Jennifer F Schultz; Jennifer R Frytak
Journal:  BMC Psychiatry       Date:  2010-06-04       Impact factor: 3.630

3.  Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors.

Authors:  Megan F Joseph; Eric A Youngstrom; Jair C Soares
Journal:  Future Neurol       Date:  2009-01-01

4.  The prevalence and correlates of workplace depression in the national comorbidity survey replication.

Authors:  Ronald C Kessler; Kathleen R Merikangas; Philip S Wang
Journal:  J Occup Environ Med       Date:  2008-04       Impact factor: 2.162

5.  Bipolar disorders in Australia. A population-based study of excess costs.

Authors:  Laura J Fisher; Robert D Goldney; Eleonora Dal Grande; Anne W Taylor; Graeme Hawthorne
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-11-01       Impact factor: 4.519

6.  The association between immune activation and manic symptoms in patients with a depressive disorder.

Authors:  K Becking; L Boschloo; N Vogelzangs; B C M Haarman; R Riemersma-van der Lek; B W J H Penninx; R A Schoevers
Journal:  Transl Psychiatry       Date:  2013-10-22       Impact factor: 6.222

7.  Why is Diagnosing MDD Challenging?

Authors:  Xiaohua Liu; Kaida Jiang
Journal:  Shanghai Arch Psychiatry       Date:  2016-12-25

8.  Quetiapine monotherapy for bipolar depression.

Authors:  Michael E Thase
Journal:  Neuropsychiatr Dis Treat       Date:  2008-02       Impact factor: 2.570

9.  Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study.

Authors:  Martin Maripuu; Mikael Wikgren; Pontus Karling; Rolf Adolfsson; Karl-Fredrik Norrback
Journal:  PLoS One       Date:  2014-06-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.